ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
54 announcements with these filters
Aster DM Quality Care issued an addendum to its 18th AGM notice, providing additional information regarding the proposed capital allocation framework for shareholders.
ICRA upgraded KIMS Healthcare Management's long-term rating to AA (Stable) from AA-, removing it from Rating Watch. The upgrade reflects stronger parent support post-Aster-QCIL merger.
Catalyst Trusteeship released a pledge and created a new hold on Aster DM Quality Care shares. The encumbrance secures term loan facilities from Barclays and JPMorgan.
UMHL released a pledge and created a non-disposal undertaking over 2.49 Cr shares securing USD 210 million. The encumbrance backs UIPL's Barclays-JPMorgan loan facilities.
Aster DM announced KIMSHEALTH New Block adding ~184 beds by May 2028 at a cost of ₹134.4 Crore. The expansion addresses space constraints in Trivandrum.
Aster DM Quality Care has submitted its Integrated Annual Report for FY 2025-26 and the notice for its 18th Annual General Meeting scheduled for September 28, 2026.
Aster DM Quality Care Ltd announced its 18th Annual General Meeting scheduled for September 28, 2026, and submitted the Integrated Annual Report for FY 2025-26.
The promoter Moopen family acquired a 0.57% additional stake in Aster DM Quality Care for Rs.350.34 Crore. This increases their total shareholding to approximately 24.58%.
Promoter group entity Union (Mauritius) Holdings Limited acquired 49,96,077 shares worth ₹419.58 Crore via open market purchases.
Aster DM Quality Care Ltd announced a capacity expansion of 184 beds at its material subsidiary, KIMS Health Care Management Limited, involving an investment of ₹134.4 Crore.
Aster DM Quality Care Limited announced the internal amalgamation of its step-down subsidiaries, Spiceretreat Hospitality and KIMSHEALTH Executive Leisure, to simplify the corporate group structure.
Aster DM Quality Care approved the amalgamation of its step-down subsidiaries, KIMSHEALTH Executive Leisure and Spiceretreat Hospitality Services. No cash consideration is involved in the scheme.
Aster DM Quality Care Ltd's subsidiary will acquire an additional 14.21% stake in STS Holdings Ltd for Rs. 420.94 Crore in cash.
Aster DM Quality Care's subsidiary acquired a 14.21% stake in STS Holdings Limited for USD 44.11 million (approx. ₹419.09 Crore) as part of a strategic investment.
Aster DM Quality Care Limited issued a Postal Ballot notice seeking shareholder approval for director appointments, remuneration revisions, and a new 2026 ESOP scheme.
Union (Mauritius) Holdings disclosed the pledge of its shares to secure loan facilities totaling USD 210 Million (₹1,995 Crore) for existing indebtedness.
Promoter BCP Asia II Topco IV Pte. Ltd. created an encumbrance over 25.89 crore shares of Aster DM Quality Care Ltd to secure a loan.
Catalyst Trusteeship Limited reported an additional pledge of 79,773,555 shares in Aster DM Quality Care Ltd. The total encumbered stake now reaches 9.7% following a merger.
Aster DM Quality Care received trading approval for 35,35,51,410 equity shares allotted under its Scheme of Amalgamation. These shares will be tradable from 17 August 2026.
Aster DM Quality Care Ltd reported its first results as a unified entity following the merger with Quality Care. Management highlights strong momentum driven by high-acuity care and operational synergies across 39 hospitals.
Aster DM Quality Care Limited is acquiring an additional 12% stake in its subsidiary, United Ciigma Institute of Medical Sciences, for ₹40.93 Crore.
Aster DM Quality Care reports strong Q1 FY27 results following a landmark merger, focusing on scale and clinical synergies across India.
Aster DM Quality Care Ltd approved the acquisition of an additional 12% stake in subsidiary United CIIGMA for Rs. 40.93 Crore, plus 18th AGM notice details.
Aster DM Quality Care Ltd reported Q1 FY27 combined proforma revenue of ₹2,597 Crore, up 20% YoY. Operating EBITDA grew 30% YoY to ₹576 Crore.
Aster DM Quality Care Q1 FY27 highlights the merger of Aster and Quality Care, reporting combined proforma revenue of INR 2,597 Cr and robust EBITDA margins.
Aster DM Quality Care Ltd reported revenue from operations of ₹1,311 Cr (+21.6% YoY) and net profit of ₹29.3 Cr (-68.7% YoY) for Q1 FY27.
Aster DM Quality Care Ltd will hold a Board of Directors meeting on August 5, 2026, to approve the company's financial results for the quarter ended June 30, 2026.
CRISIL has assigned 'Crisil AA+/Stable' and 'Crisil A1+' ratings to Aster DM Quality Care Limited's bank facilities totaling ₹860.50 Crore.
Aster DM Healthcare Limited is changing its corporate name to Aster DM Quality Care Limited, effective July 28, 2026.
Aster DM promoters' stake diluted from 40.39% to 24.01% following an equity allotment under a Scheme of Amalgamation. This resulted in a 16.38% stake decrease.